TABLE 4.
Summary of sensitivity and specificity of AMR genes for prediction of phenotypic resistancec
| Organism | Aminopenicillin | shv and/or tem (in isolates without ctx-m/ampC) | Third-generation cephalosporins | ctx-m and/or ampC | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Det | ND | Sens. | Spec. | PPV | NPV | Det. | ND | Sens. | Spec. | PPV | NPV | |||
| Escherichia coli (n = 58) | Resistant | 18 | 1 | 94.7% | 95.8% | 94.7% | 95.8% | Resistant | 16 | 0 | 100.0% | 100.0% | 100.0% | 100.0% |
| Susceptible | 1 | 23 | Susceptible | 0 | 42 | |||||||||
| Klebsiella pneumoniae groupa (n = 32) | Resistant | N/A – intrinsic resistance to aminopenicillins | Resistant | 5 | 0 | 100.0% | 100.0% | 100.0% | 100.0% | |||||
| Susceptible | Susceptible | 0 | 26 | |||||||||||
| Organism | Gentamicin | aac(6’)-lb | Amikacin | aac(6’)-lb | ||||||||||
| Det | ND | Sens. | Spec. | PPV | NPV | Det. | ND | Sens. | Spec. | PPV | NPV | |||
| Escherichia coli (n = 58) | Resistant | 2 | 5 | 28.6% | 98.0% | 66.7% | 90.9% | Resistant | 1 | 0 | 100.0% | 96.5% | 33.3% | 100.0% |
| Susceptible | 1 | 50 | Susceptible | 2 | 55 | |||||||||
| Klebsiella pneumoniae groupa (n = 32) | Resistant | 3 | 1 | 75.0% | 100.0% | 100.0% | 96.6% | Resistant | 0 | 0 | - | 90.6% | 0.0% | 100.0% |
| Susceptible | 0 | 28 | Susceptible | 3 | 29 | |||||||||
| Organism | Penicillin | blaZ (in isolates without mecA) | Cloxacillin | mecA | ||||||||||
| Det | ND | Sens. | Spec. | PPV | NPV | Det. | ND | Sens. | Spec. | PPV | NPV | |||
| Staphylococcus aureus (n = 11) | Resistant | 3 | 0 | 100.0% | 100.0% | 100.0% | 100.0% | Resistant | 7 | 0 | 100.0% | 100.0% | 100.0% | 100.0% |
| Susceptible | 0 | 1 | Susceptible | 0 | 4 | |||||||||
| Coagulase-negative Staphylococcusb (n = 11) | Resistant | N/A – No break points for penicillin | Resistant | 7 | 0 | 100.0% | 100.0% | 100.0% | 100.0% | |||||
| Susceptible | Susceptible | 0 | 8 | |||||||||||
| Organism | Gentamicin | aac(6’)/aph(2”) | Minocycline Sens. |
tetM | ||||||||||
| Det | ND | Sens. | Spec. | PPV | NPV | Det | ND | Sens. | Spec. | PPV | NPV | |||
| All Staphylococcus spp.b (n = 22) | Resistant | 8 | 0 | 100.0% | 100.0% | 100.0% | 100.0% | Resistant | 0 | 0 | - | 100.0% | - | 100.0% |
| Susceptible | 0 | 15 | Susceptible | 0 | 22 | |||||||||
| Organism | Erythromycin | ermC | Clindamycin | ermC | ||||||||||
| Det | ND | Sens. | Spec. | PPV | NPV | Det. | ND | Sens. | Spec. | PPV | NPV | |||
| All Staphylococcus spp.b (n = 22) | Resistant | 6 | 1 | 85.7% | 87.5% | 75.0% | 93.3% | Resistant | 6 | 0 | 100.0% | 100.0% | 100.0% | 100.0% |
| Susceptible | 2 | 14 | Susceptible | 0 | 17 | |||||||||
Includes 31 K. pneumoniae and one K. variicola isolate.
Detailed breakdown is available in the supplemental material.
Det, detected; ND, not detected: sens., sensitivity; spec., specificity; PPV, positive predictive value; NPV, negative predictive value; N/A, not applicable.